Mercer Global Advisors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.47M | Sell |
135,497
-29,010
| -18% | -$2.03M | 0.02% | 369 |
|
|
2025
Q1 | $12.1M | Buy |
164,507
+4,383
| +3% | +$322K | 0.03% | 317 |
|
|
2024
Q4 | $10.5M | Buy |
+160,124
| New | +$10.5M | 0.03% | 348 |
|
|
2024
Q1 | – | Sell |
-130,929
| Closed | -$8.82M | – | 2002 |
|
|
2023
Q4 | $8.82M | Sell |
130,929
-10,087
| -7% | -$679K | 0.03% | 333 |
|
|
2023
Q3 | $9.55M | Buy |
141,016
+18,453
| +15% | +$1.25M | 0.04% | 279 |
|
|
2023
Q2 | $8.77M | Buy |
122,563
+6,205
| +5% | +$444K | 0.03% | 322 |
|
|
2023
Q1 | $8.08M | Buy |
116,358
+238
| +0.2% | +$16.5K | 0.04% | 318 |
|
|
2022
Q4 | $7.87M | Buy |
116,120
+16,540
| +17% | +$1.12M | 0.04% | 320 |
|
|
2022
Q3 | $5.46M | Buy |
99,580
+243
| +0.2% | +$13.3K | 0.03% | 359 |
|
|
2022
Q2 | $6.56M | Buy |
99,337
+5,543
| +6% | +$366K | 0.04% | 296 |
|
|
2022
Q1 | $6.22M | Buy |
93,794
+4,451
| +5% | +$295K | 0.04% | 329 |
|
|
2021
Q4 | $5.2M | Buy |
89,343
+11,275
| +14% | +$657K | 0.03% | 362 |
|
|
2021
Q3 | $4.69M | Buy |
78,068
+31,939
| +69% | +$1.92M | 0.03% | 365 |
|
|
2021
Q2 | $2.76M | Buy |
46,129
+7,289
| +19% | +$437K | 0.02% | 469 |
|
|
2021
Q1 | $1.93M | Buy |
38,840
+5,208
| +15% | +$259K | 0.02% | 531 |
|
|
2020
Q4 | $1.68M | Sell |
33,632
-1,047
| -3% | -$52.3K | 0.02% | 468 |
|
|
2020
Q3 | $1.9M | Buy |
34,679
+4,715
| +16% | +$258K | 0.03% | 397 |
|
|
2020
Q2 | $1.59M | Buy |
29,964
+320
| +1% | +$16.9K | 0.03% | 371 |
|
|
2020
Q1 | $1.32M | Buy |
29,644
+2,857
| +11% | +$128K | 0.03% | 402 |
|
|
2019
Q4 | $1.34M | Buy |
26,787
+1,978
| +8% | +$98.7K | 0.03% | 443 |
|
|
2019
Q3 | $1.11M | Buy |
24,809
+3,860
| +18% | +$172K | 0.03% | 458 |
|
|
2019
Q2 | $865K | Buy |
20,949
+1,596
| +8% | +$65.9K | 0.02% | 503 |
|
|
2019
Q1 | $782K | Buy |
+19,353
| New | +$782K | 0.03% | 485 |
|